Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor-Reference-Cited by-同舟云学术

Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

Published:2015-02-06 Issue:4 Volume:68 Page:320-321
ISSN:0021-9746
Container-title:Journal of Clinical Pathology
language:en
Short-container-title:J Clin Pathol

Author:

Kuiper Justine L,Ronden Merle I,Becker Annemarie,Heideman Daniëlle A M,van Hengel Peter,Ylstra Bauke,Thunnissen Erik,Smit Egbert F

Publisher

BMJ

Subject

General Medicine,Pathology and Forensic Medicine

Reference7 articles.

1. Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)

2. Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers

3. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology

4. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

5. Gene mutations in squamous cell NSCLC: insignificance of EGFR, KRAS and PIK3CA mutations in prediction of EGFR-TKI treatment efficacy;Fiala;Anticancer Res,2013

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity;Molecular Cancer;2023-12-13

2. Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial;iScience;2023-09

3. Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinoma;npj Precision Oncology;2023-08-26

4. Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review;Translational Lung Cancer Research;2023-04

5. Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications;Critical Reviews in Oncology/Hematology;2023-04